Trials and Tribble-ations of tissue T rm cells
A n effective memory T cell response is based on tiered layers of defense that often begin with locally poised CD8 + T RM cells. In this issue of Nature Immunology, Beura et al. 1 and Park et al. 2 describe the early and late effects of secondary infection on pre-existing T RM cell pools in two mucosal tissues, the skin and the female reproductive tract (FRT), and show that CD8 + T RM cells proliferate in situ to generate a secondary pool of T RM cells that does not exit into the circulation. Although CD8 + memory T cells recruited from the circulation (T CIRC cells) may also take up residence in the reinfected tissue, they do not outcompete the pre-existing T RM cell population 1, 2 .
CD8
+ memory T cells are a heterogeneous population of cells that can be conceptually segregated on the basis of their functional and spatial properties. Three memory T cell populations have been shown to circulate between the blood and organs: central memory T cells (T CM cells), characterized by their high expression of lymph node (LN)-homing receptors, regenerative potential and interleukin 2 (IL-2) production; effector memory T cells (T EM cells), distinguished by low expression of LN-homing receptors and high expression of CX3CR1, and which predominantly survey the blood and exert immediate cytotoxic functions; and peripheral memory T cells (T PM cells), which are CX3CR1 int and preferentially patrol peripheral tissues via a distinct pattern of migration from blood to tissue to lymph. A fourth population of CD8 + memory T cells, the T RM cells, derived from CX3CR1 lo/int and KLRG1 lo effector T cells and commonly distinguished by their increased expression of CD69 and CD103, do not recirculate in the host, but rather dwell long-term within tissues to provide rapid local protection. Such spatial compartmentalization of memory T cells provides a shield of protective immunity acting both outside-in and inside-out.
Poised at the front lines of defense, often within epithelial barriers, CD8
+ T RM cells serve as motile sentinels that patrol the tissue microenvironment for reinfection 3 ( Fig. 1) . Intravital imaging by Park et al. 2 and Beura et al. 1 revealed different rates of motility of T RM cells in the skin and FRT, with mean velocities of 2 μ m min -1 and 10 μ m min -1 , respectively. Notably, in the FRT, CD8
+ T cell velocity is slower down in the collagen-rich perimetrium than in the myometrium 1 , possibly because of the unique tissue architectures and densities of the two regions. This is akin in some ways to the situation in the skin, where CD8 + T cell velocities are significantly faster in the dermis than in the epidermis 3 . Given the seemingly random motion of these motile CD8
+ T RM cells, it will be informative to learn whether they preferentially interact with cells that express survival-cue proteins such as IL-15 and TGF-β .
A body of literature has informed on how T CM cells and T EM cells respond during secondary infection, but less is known about how T RM cells respond in situ. The prevailing idea in the field was that T RM cells had little self-renewal potential at steady state, and that upon reinfection T CM cells dominated the recall response owing to their increased proliferative capacity. By elegantly delineating the responses of T CIRC cells and T RM cells, Park et al. 2 and Beura et al. 1 demonstrate that pre-existing T RM cells undergo local proliferation in situ during reinfection. Whether there is a distinct subpopulation of T RM cells with regenerative capacity remains to be explored. Importantly, the secondary pool of T RM cells after reinfection is generated predominantly from the pre-existing, proliferating T RM cells, rather than from the circulating memory T cells recruited into the inflamed tissue. , the present data suggest that when reactivated in situ, T RM cells maintain their cell fate identity and do not re-enter the circulation. Perhaps this occurs because the T RM cells further upregulate CD69 after reactivation, thereby preventing S1P-mediated egress into the blood or lymph. As prior work has demonstrated that secondary or tertiary 'experienced' T CIRC cells can become qualitatively different with each successive round of infection 5, 6 , it will be interesting to further investigate the quality, longevity and function of these secondary T RM cells compared with those of primary T RM cells.
Comprehensive studies are beginning to discern the tissue-specific requirements for T RM cell formation and maintenance. For instance, T RM cells in the skin, salivary gland and kidney require IL-15 for their homeostatic maintenance, whereas those in the FRT or small intestine do not 7 1, 2 . Perhaps such tissue-specific effects stem from differences in the bioavailability of TGF-β , a hallmark cytokine for the induction of CD103 expression 8, 12 . The mucosal tissues are constantly exposed to different environmental challenges. Secondary heterologous infection in the lung can drive the migration of pre-existing CD8
+ memory T cells into the bronchoalveolar spaces 13 . Whether these recruited memory T cells belong to lung T RM cells or T CIRC cells remains to be investigated, but this observation raises the question of whether successive waves of heterologous infection and inflammation can cause the pre-existing pool of T RM cells to shrink, expand or change qualitatively. In a series of heterologous rechallenges via varying infection routes, Park et al. observed that despite the influx and seeding of new T RM cells, the number of pre-existing T RM cells remained mostly unaltered 2 , which indicates that T RM cells persist long-term and that the entire T RM cell pool is expandable within tissues. This is consistent with previous observations that the memory T CIRC cell population is a flexible compartment that can accommodate increased numbers of CD8 + memory T cells after heterologous prime-boost vaccinations 14 . Stressed-out ROS take a silent death route
Detrimental levels of intracellular reactive oxygen species engage a caspase-independent and non-inflammatory cell death called 'oxeiptosis' that serves as an important mechanism in diminishing inflammation.
Sannula Kesavardhana and Thirumala-Devi Kanneganti R eactive oxygen species (ROS) are generated as byproducts of metabolic activity, infection and pathological disease conditions 1, 2 . Depending on the amount of ROS produced, intracellular ROS mediate either physiological signal transduction or detrimental effects. In this issue of Nature Immunology, Holze et al. report that toxic levels of ROS trigger a caspase-independent cell death that they call 'oxeiptosis' 3 ( Fig. 1) . Physiologically, oxeiptosis seems to have an important role in diminishing stress-or infectionassociated inflammation and injury.
Stress-and infection-induced ROS contribute to pathological manifestations 1, 2 . Detrimental ROS production promotes mitochondrial membrane permeability and subsequent activation of apoptosis or necrosis 2, 4 . Although ROS-mediated cellular perturbations are well studied, the molecular underpinnings that regulate ROS-mediated physiological or detrimental functions are not fully known. Holze et al. observe the accumulation of ROS in airway epithelial cells after treatment with ozone, a potent inducer of oxidative stress, which leads to severe inflammation 3 . Surprisingly, they find that this severe inflammation is independent of the inflammasome (a multiprotein complex that triggers pro-inflammatory cytokines) and apoptotic caspase activity, which suggests the activation of unknown pathways in ozone-induced inflammation and cell death. Similarly they find that treatment with H 2 O 2 (another inducer of oxidative stress) activates a form of cell death with a characteristic membraneblebbing morphology that mimics apoptosis but lacks caspase activation. This cell death is resistant to biochemical inhibitors of apoptosis, necroptosis and ferroptosis, with no differences in autophagy. These findings clearly demonstrate that the production of ROS executes a unique apoptotic-like cell death that Holze et al. call 'oxeiptosis' 3 . It is well established that intracellular ROS can also activate caspase-dependent apoptosis or pyroptosis 1, 5 . In addition, redundancies among multiple cell-death pathways have been studied in great detail [6] [7] [8] . The results of
